HOSTED ON CAMPUS BY:
ORGANIZED WITH:
The 2nd Annual Digital Breakthrough for Pharma Summit 2026 focuses on the evolving digital health landscape and the impact of novel technologies in the life sciences. Join us to hear how digital health is impacting everything from patient monitoring to diagnosis and treatment and driving better health outcomes for patients across the board.
Join 25+ speakers and senior-level life sciences, research, drug development and digital health executives this June 2nd at BMS Princeton Pike to hear about the latest trends in digital health and AI and to network with peers and colleagues across the value chain.
Location
BMS Princeton Pike Campus
3401 Princeton Pike, Lawrence Township, NJ 08648
3401 Princeton Pike, Lawrence Township, NJ 08648
Date & Time
June 2, 2026
8:00am - 5:00pm
8:00am - 5:00pm
2026 CORE THEMES
1. GenAI in Patient Care: From Clinical Insight to Care Impact
• How GenAI is beginning to improve diagnosis, monitoring, and treatment support in ways that matter to patients and clinicians
• What will determine whether these tools are used in practice: clinical trust, human oversight, and clear value in care
• Where the field is heading next as AI becomes more embedded in how patients are supported and how care decisions are made
2. Evidence & Regulatory: Digital Measures as Fit‑for‑Purpose Clinical Evidence
• How can pharma turn digital measures into regulatory-ready evidence that accelerates development, supports approvals, and enables differentiated labeling?
• As FDA expectations for digital health, real-world evidence, and novel endpoints evolve, how can sponsors engage early and align strategically?
• Digital tools now need clear analytical validation, clinical relevance, and context of use—are your measures truly generating data that supports your scientific and regulatory goals?
3. Building to Scale: Turning Digital Innovation into Clinical Impact
• How leading organizations are deploying AI, wearables, and precision medicine platforms to create real value in care
• What it takes to scale digital solutions in practice: clear clinical use cases, workflow fit, measurable outcomes, and equitable reach
• How to build the infrastructure for scale: the right partnerships, data flows, and operating model to sustain adoption
4. Brain Health: The Digital Opportunity Across the Care Journey
• How digital can close the brain health measurement gap: moving from subjective, episodic assessments to continuous, objective signals that are clinically meaningful, and better suited for trials and care
• How digital can strengthen brain health care across the journey: supporting earlier identification, sustained engagement, adherence, caregiver support, and timely intervention
• What it takes to scale brain health digital solutions responsibly: designing for trust, access, safety, and long-term use so these tools work in the real world
2026 Speakers
Greg Meyers
EVP, Chief Digital & Technology Officer
(Conference Executive Sponsor)
EVP, Chief Digital & Technology Officer
(Conference Executive Sponsor)
Matteo di Tommaso
SVP, R&D BI&T
(Conference Executive Sponsor)
SVP, R&D BI&T
(Conference Executive Sponsor)
Seemi Kazmi
Executive Director, Digital Health
(Conference Executive Sponsor)
Executive Director, Digital Health
(Conference Executive Sponsor)
Bisrat Woldemichael
Director, Digital Health, Neuroscience
(Conference Chair)
Director, Digital Health, Neuroscience
(Conference Chair)
Doxie Jordan
Global Head of Commercial Strategy
Global Head of Commercial Strategy
Jeremy Mann
VP, Customer Experience, Neuroscience
VP, Customer Experience, Neuroscience
John Duffield
Patient Survivor, Health Futurist
Patient Survivor, Health Futurist
Jennifer Goldsack
CEO
CEO
Erica Moore
Director of Operations
Director of Operations
Nicklas Linz
CEO
CEO
Katie Jackson
Director, Global Regulatory Policy
Director, Global Regulatory Policy
Viprali Bhatkar
Sr. Director, Digital Health
Sr. Director, Digital Health
Jacqueline Thong
General Manager, US
General Manager, US
Ania Bilski
VP, Clinical AI
VP, Clinical AI
Orr Inbar
CEO
CEO
Sebastian Jayaraj
Sr. Director, Digital Health
Sr. Director, Digital Health
Brian Piening
Program Director, Providence Genomics
Program Director, Providence Genomics
Zain Asad
Associate Professor
Associate Professor
Anja Kahl
Executive Director of Global Clinical Development
Executive Director of Global Clinical Development
Abhishek Pratap
Executive Director, Global Evidence Lead
Executive Director, Global Evidence Lead
Matteo Lai
CEO
CEO
Leslie Oley Wilberforce
CEO
CEO
Jill Bell
Chief Science Officer
Chief Science Officer
Ahad Wahid
President, Life Sciences
President, Life Sciences
Bhavna Adhin
Director, Digital and Imaging Clinical Informatics
Director, Digital and Imaging Clinical Informatics
Dr. Daniel Karlin
Psychiatrist, Chief Medical Officer
Psychiatrist, Chief Medical Officer
Chris McGhee
CEO
CEO
Sundeep Govathoti
Director, Health & Life Sciences
Director, Health & Life Sciences
Summit Planning Team
Jay Brown
Senior Manager Product Management, Digital Health
Senior Manager Product Management, Digital Health
BRISTOL MYERS SQUIBB
Alexis Campolongo
Digital Accelerator Dev Program Lead, Digital Health
Digital Accelerator Dev Program Lead, Digital Health
BRISTOL MYERS SQUIBB
Sonal Pai
Senior Director, External Innovation and AI Partnership
Senior Director, External Innovation and AI Partnership
BRISTOL MYERS SQUIBB
Connie Lieu
Director, Head of IT, US Hematology, Oncology
Director, Head of IT, US Hematology, Oncology
BRISTOL MYERS SQUIBB
Jalpa Dave
Director, Digital & IT lead, US Immunology, Cardiovascular
Director, Digital & IT lead, US Immunology, Cardiovascular
BRISTOL MYERS SQUIBB
Evan Segerman
Associate Director, Leadership Communication
Associate Director, Leadership Communication
BRISTOL MYERS SQUIBB
Manisha Agarwal
Digital Health
Team
Digital Health
Team
BRISTOL MYERS SQUIBB
2026 Conference Agenda
8:00 AM - 9:00 AM
REGISTRATION AND BREAKFAST NETWORKING
9:00 AM - 9:10 AM
Welcoming Words and Introduction
Seemi Kazmi, Executive Director, Digital Health, Bristol Myers Squibb (Conference Executive Sponsor)
GenAI in Patient Care: From Clinical Insight to Care Impact
• What will determine whether these tools are used in practice: clinical trust, human oversight, and clear value in care
• Where the field is heading next as AI becomes more embedded in how patients are supported and how care decisions are made
9:10 AM - 9:30 AM
AI as a Lifeline: A First-hand Account of Using AI for Survival, Patient Advocacy and Health Literacy
John Duffield, Patient Survivor, Health Futurist
9:30 AM - 9:50 AM
The Next Generation of Clinical Intelligence
Ania Bilski, VP of Clinical AI, OpenEvidence
9:50 AM - 10:20 AM
PANEL DISCUSSION:
GenAI: Opportunities and Considerations for Patients, HCPs and Pharma Stakeholders
GenAI: Opportunities and Considerations for Patients, HCPs and Pharma Stakeholders
• How GenAI is beginning to improve diagnosis, monitoring, and treatment support in ways that matter to patients and clinicians
• What will determine whether these tools are used in practice: clinical trust, human oversight, and clear value in care
• Where the field is heading next as AI becomes more embedded in how patients are supported and how care decisions are made
John Duffield, Patient Survivor, Health Futurist
Orr Inbar, CEO, QuantHealth
Nate Brown, Strategic Account Partner, Veeva Ostro
Speaker TBA, NVIDIA
Moderated by:
Seemi Kazmi, Executive Director, Digital Health, Bristol Myers Squibb
10:20 AM - 10:50 AM
NETWORKING BREAK
Evidence & Regulatory: Architecting Trust from Day One
• As FDA expectations for digital health, real-world evidence, and novel endpoints evolve, how can sponsors engage early and align strategically?
• Digital tools now need clear analytical validation, clinical relevance, and context of use—are your measures truly generating data that supports your scientific and regulatory goals?
Session Chair
Viprali Bhatkar, Sr. Director, Digital Health, Bristol Myers Squibb
10:50 AM - 11:05 AM
Evidence by Design: Building Digital Health Products That Earn Trust
Jennifer Goldsack, CEO, The Digital Medicine Society (DiMe)
11:05 AM - 11:20 PM
Real-World Evidence at Scale: Connecting Everyday Life to Clinical Proof
Nicklas Linz, CEO, ki:elements
11:20 AM - 11:35 PM
HAWKS (Hub for Assurance and Watching for Key Digital Signals)
Bhavna Adhin, Director, Digital and Imaging Clinical Informatics, Pfizer
11:35 PM - 12:00 PM
PANEL DISCUSSION:
Evidence & Regulatory: Architecting Trust from Day One
Evidence & Regulatory: Architecting Trust from Day One
• How can pharma turn digital measures into regulatory-ready evidence that accelerates development, supports approvals, and enables differentiated labeling?
• As FDA expectations for digital health, real-world evidence, and novel endpoints evolve, how can sponsors engage early and align strategically?
• Digital tools now need clear analytical validation, clinical relevance, and context of use—are your measures truly generating data that supports your scientific and regulatory goals?
Katie Jackson, Director, Global Regulatory Policy, Bristol Myers Squibb
Jacqueline Thong, General Manager, US, DEEP Measures
Matteo Lai, CEO, Empatica
Jill Bell, Chief Science Officer, Evinova
Anja Kahl, Executive Director of Global Clinical Development, Bristol Myers Squibb
Moderated by:
Viprali Bhatkar, Director, Digital Health, Bristol Myers Squibb
12:00 pM - 1:10 pM
NETWORKING LUNCH
Building to Scale: Turning Digital Innovation into Clinical Impact
• What it takes to scale digital solutions in practice: clear clinical use cases, workflow fit, measurable outcomes, and equitable reach
• How to build the infrastructure for scale: the right partnerships, data flows, and operating model to sustain adoption
Session Chair
Sebastian Jayaraj, Senior Director of Digital Health, Bristol Myers Squibb
1:10 PM - 1:25 PM
NextGen AI for Precision Medicine at Scale
Sundeep Govathoti, Director, Health & Life Sciences, Microsoft
1:25 PM - 1:40 PM
From Models to Medicine: Deploying AI‑Enabled Precision Oncology Across a Diverse Health System
Brian Piening, Program Director, Providence Genomics, Providence Health
1:40 PM - 1:55 PM
From the Cardiology Clinic to a Trial: A Guide to Implementing Remote Monitoring Data in Oncology
Dr. Zain Asad, Associate Professor, Oklahoma University Health
1:55 PM - 2:25 PM
PANEL DISCUSSION:
Zero to Impact: Successfully Scaling AI in Healthcare
Zero to Impact: Successfully Scaling AI in Healthcare
• How leading organizations are deploying AI, wearables, and precision medicine platforms to create real value in care
• What it takes to scale digital solutions in practice: clear clinical use cases, workflow fit, measurable outcomes, and equitable reach
• How to build the infrastructure for scale: the right partnerships, data flows, and operating model to sustain adoption
Brian Piening, Program Director, Providence Genomics, Providence Health
Chris McGhee, CEO, Current Health
Ahad Wahid, President, Life Sciences, Hippocratic AI
Moderated by: Sebastian Jayaraj, Senior Director of Digital Health, BMS
2:25 PM - 2:45 PM
NETWORKING BREAK
Brain Health: The Digital Opportunity Across the Care Journey
• How digital can close the brain health measurement gap: moving from subjective, episodic assessments to continuous, objective signals that are clinically meaningful, and better suited for trials and care
• How digital can strengthen brain health care across the journey: supporting earlier identification, sustained engagement, adherence, caregiver support, and timely intervention
• What it takes to scale brain health digital solutions responsibly: designing for trust, access, safety, and long-term use so these tools work in the real world
Session Chair
Bisrat Woldemichael, Director, Digital Health – CV and Neuroscience, Bristol Myers Squibb
2:45 PM - 3:05 PM
Keynote TBA
Speaker TBA, Bristol Myers Squibb
3:05 PM - 3:25 PM
The Measurement & Execution Gap: An Underappreciated Driver of CNS Trial Failure
Abhishek Pratap, Executive Director, Global Evidence Lead, CNS, Boehringer Ingelheim
3:25 PM - 4:00 PM
PANEL DISCUSSION:
Brain Health as a Public Health Priority: Measurement, Access, and the Role of Technology
Brain Health as a Public Health Priority: Measurement, Access, and the Role of Technology
• How digital can close the brain health measurement gap: moving from subjective, episodic assessments to continuous, objective signals that are clinically meaningful, and better suited for trials and care
• How digital can strengthen brain health care across the journey: supporting earlier identification, sustained engagement, adherence, caregiver support, and timely intervention
• What it takes to scale brain health digital solutions responsibly: designing for trust, access, safety, and long-term use so these tools work in the real world
Doxie Jordan, Head of Global Commercial Strategy, Bristol Myers Squibb
Erica Moore, Director of Operations, The STARR Coalition
Leslie Oley Wilberforce, CEO, Evidation
Dr. Daniel Karlin, Psychiatrist, Chief Medical Officer, Definium Therapeutics
Moderated by:
Jeremy Mann, VP, Customer Experience, Neuroscience, Bristol Myers Squibb
4:00 PM - 4:10 PM
CONCLUDING REFLECTIONS
Greg Meyers, EVP, Chief Digital and Technology Officer, Bristol Myers Squibb
(Conference Executive Sponsor)
4:10 PM - 4:15 PM
CONCLUDING REMARKS
Matteo di Tommaso, SVP, R&D BI&T, Bristol Myers Squibb
(Conference Executive Sponsor)
4:15 PM - 5:15 PM
NETWORKING RECEPTION
2026 Sponsors
VENUE HOST
GOLD SPONSOR
GOLD SPONSOR
GOLD SPONSOR
SILVER SPONSOR
SILVER SPONSOR
SILVER SPONSOR
SILVER SPONSOR
SILVER SPONSOR
SILVER SPONSOR
SILVER SPONSOR
SILVER SPONSOR
EXHIBITOR
EXHIBITOR
2025 Event Photo Gallery
Interested in Attendance, Sponsorship or Exhibition Opportunities?
Location
Bristol Myers Squibb Princeton Pike Campus
Lawrence Township, NJ
Lawrence Township, NJ
The newly constructed 650,000-square foot facility opened in November 2016 and houses employees from the commercial teams, their commercialization and late-stage development partners from Research & Development and Global Product Development & Supply, and their enabling function support teams.
Join us at the 2nd Annual
Digital Breakthrough for Pharma Summit 2026!
Digital Breakthrough for Pharma Summit 2026!
From the latest in patient monitoring, blueprints for successful digital engagement and yes, even AI, you'll learn winning strategies that are delivering better experiences for patients, their caregivers, and physicians.